Home/ Supplements/ Vitamin K/ Vitamin K2 45 mcg

Vitamin K2 45 mcg

product on market Softgel Capsule Nutri-Rich Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 is associated with supporting bone health and cardiovascular function by regulating calcium deposition. There is moderate evidence suggesting it helps prevent arterial calcification and improves bone mineral density. The current formulation provides a low dose of this nutrient.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K2 45 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
90
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

45 mcg (56% DV)
Within RDA (0.4× RDA) 275 studies (A:9, B:175)

Other Ingredients

extra virgin Olive Oil Gelatin Glycerin purified Water Carob
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take 1 softgel daily.

Warnings & Precautions

Note: If you take anticoagulants such as warfarin, please consult your physician before use. If you are pregnant, nursing, or taking any medications, consult your physician before use.

Store in a cool, dry place, away from the reach of children.

Formulation Notes

We use a soy-free form that is naturally fermented and blend it with extra virgin Olive Oil for extra health benefits.

We use a soy-free form that is naturally fermented and blend it with extra virgin Olive Oil for extra health benefits.

Sugar free Gluten free No artificial additives Non-GMO

Vitamin K2 45mcg Vitamin K2 as MK-7

Superior MK-7 form is natural and easily absorbed.

Additional Information

Vitamin K2 supports healthy arteries and works synergistically with calcium for strong bones. It is not synethesized by our bodies and typically deficient in our diets.

Third-party quality tested NSF GMP certified facility

Made in the USA

Supports arterial health and strong bones.

Store in a cool, dry place, away from the reach of children.

Metadata

Product Details

UPC / SKU6 19176 10081 2
DSLD Entry Date2018-04-25
Product TypeVitamin
FormSoftgel Capsule
DSLD ID176554
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.